Drug intelligence / Profile preview

ephedrine + phenylephrine (Centre Hospitalier Universitaire de Clermont-Ferrand)

Development stage
Unknown
Lead developer
Centre Hospitalier Universitaire de Clermont-Ferrand
Modality
Small Molecules
Administration
Intravenous
01

Overview

Ephedrine and phenylephrine are sympathomimetic vasopressors used to manage intraoperative hypotension. This specific entry refers to a clinical trial (NCT01141374) conducted by University Hospital, Clermont-Ferrand, which compared the efficacy and safety of these two agents in patients undergoing carotid endarterectomy. Ephedrine acts as a non-selective agonist at alpha- and beta-adrenergic receptors and also promotes the release of endogenous norepinephrine, providing both vasoconstrictive and inotropic effects. Phenylephrine is a selective alpha-1 adrenergic receptor agonist that primarily increases systemic vascular resistance through potent vasoconstriction. The study aimed to determine if the pure alpha-adrenergic activity of phenylephrine might negatively impact cerebral perfusion compared to the mixed adrenergic profile of ephedrine during periods of accidental hypotension.

Other names
ephedrine and phenylephrine
02

Targets

ADRA1A (α1A)ADRA2A (α2A)ADRB2 (β2)ADRB1 (β1)

Beyond the preview

Go deeper on ephedrine + phenylephrine (Centre Hospitalier Universitaire de Clermont-Ferrand).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ephedrine + phenylephrine (Centre Hospitalier Universitaire de Clermont-Ferrand).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call